Your Article Summary
See Latest ArticlesShould the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended
Current Opinion in Oncology, 06/16/09
Klastersky J et al. - It is likely that the consideration of these newly recognized risk factors and the availability of more affordable granulocyte colony-stimulating factors will lead, in the near future, to an extension of the presently recognized indications for the prescription of granulocyte colony-stimulating factors.
Related Articles
Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review
Clinical Therapeutics, 10/29/09
Relevance Score: 91%
Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies
Critical Care, 11/06/09
Relevance Score: 90%
Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03
British Journal of Cancer, 10/01/09
Relevance Score: 85%
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence
World Journal of Gastroenterology, 11/19/09
Relevance Score: 84%
Antibiotic-induced Severe Neutropenia with Multidrug-Dependent Antineutrophil Antibodies Developed in A Child with Streptococcus pneumoniae Infection
Journal of Korean Medical Science, 10/06/09
Relevance Score: 83%
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary Alveolar Proteinosis as a Terminal Complication in a Case of Myelodysplastic Syndrome with idic(20q-)
Acta Haematologica, 12/04/09
Environmental-mediated drug resistance: a target for multiple myeloma therapy
Expert Review of Hematology, 12/02/09
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoglobulin G Fc Receptor FcgammaRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Journal of Clinical Oncology, 12/04/09
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Journal of Clinical Oncology, 12/04/09
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver
The Oncologist, 12/03/09